Search

everythinglearnresearchcommunity

for

Search:↓

A woman's shingles infection triggered her first episode of a rare neurological disorder and blood vessel inflammation.

Computational tools identified 29 drugs that could potentially target 19 genes involved in chemotherapy-induced hair loss, which could lead to more effective treatments.

New vitiligo treatments focus on controlling immune damage and restoring skin color.

Applying a DNA vaccine to skin with active hair growth boosts immune response and protection against anthrax in mice.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

Brain-Derived Neurotrophic Factor (BDNF) slows down hair growth and promotes hair follicle regression.

Frontal fibrosing alopecia may be linked to genital Lichen sclerosus through an autoimmune process.

M30 is a promising treatment for preventing hair loss during chemotherapy.

Melatonin is important for skin health and protection, and can be made by the skin or applied to it.

Zinc is effective for treating various skin conditions, including warts and acne.

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

No treatment fully prevents hair loss from chemotherapy yet.

HIV can cause unusual and severe skin problems that are hard to treat.

Some plants may help with hair growth and have fewer side effects than synthetic drugs, but more research is needed to confirm their effectiveness.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

BTA safely and effectively treats hair loss, and works better with FNS.

Common types of non-scarring hair loss have various causes and treatments, but more effective solutions are needed.

Platelet-Rich Plasma (PRP) can promote new hair growth and increase hair density, but its effectiveness varies depending on the type of hair loss.

Future work on macrolide antibiotic analysis will aim to enhance selectivity, sensitivity, and efficiency using advanced chromatographic methods.

Hair loss in children is diagnosed and treated differently than in adults, with different common causes and a focus on less invasive methods.

Several new treatments for different types of hair loss show promise in improving patient quality of life.

Ginsenoside Rg1 protects mouse skin from UVB damage and helps control inflammation.

Putting thymidine dinucleotide on newborn mice's skin can delay and reduce skin cancer.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Afro-textured hair is more fragile and prone to certain scalp conditions, requiring careful treatment and more research for effective management.

The document explains the causes, types, diagnosis, and treatments of hair loss, and its psychological impact, especially on women.